About Apithecary Pharma Private Limited
Data last updated:
Apithecary Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC047834. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.26 Cr. It is led by directors Munnamgi Radhika Reddy (Managing Director) and Munnamgi Anoushka Reddy.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla Village, Hyderabad, Telangana, India – 500067.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.67 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Lakh (net margin 63.3%) and EBITDA of ₹1.06 Lakh (EBITDA margin 63.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
As per MCA filings, the company has satisfied charges of ₹14.53 Cr on record. Court records list 13 cases involving the company, including 9 filed by the company and 4 filed against it. The company has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Naturalle Health Products Pvt Ltd with revenue of ₹1.72 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apithecary.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No. 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla Village, Hyderabad, Telangana, India – 500067
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Apithecary Pharma Private Limited
The main business activity of Apithecary Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apithecary Pharma Private Limited FY 2025 filings available
Apithecary Pharma Private Limited reported revenue of ₹1.67 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Apithecary Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 17% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apithecary Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.06 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apithecary Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 63.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 63.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apithecary Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Apithecary Pharma Private Limited
Apithecary Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Naturalle Health Products Pvt Ltd | ₹1.72 Lakh (FY 2024) | •••• | •••• | 1336.0% | •••• | Hyderabad, Telangana, India |
| Biomarq Labs Private Limited | ₹1.71 Lakh (FY 2025) | •••• | •••• | 67.0% | •••• | Dehradun, Uttarakhand, India |
| PNJT Realty Private Limited | ₹1.69 Lakh (FY 2024) | •••• | •••• | -74.0% | •••• | Mumbai, Maharashtra, India |
| Ayurvisharada Formulations Private Limited | ₹1.69 Lakh (FY 2025) | •••• | •••• | •••• | Sringeri, Karnataka, India | |
| Vidalife Pharma Private Limited | ₹1.69 Lakh (FY 2025) | •••• | •••• | -97.0% | •••• | Jogeshwari East, Maharashtra, India |
| Apithecary Pharma Private Limited this company | ₹1.67 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Hants Laboratories Private Limited | ₹1.65 Lakh (FY 2024) | •••• | •••• | •••• | North East, Delhi, India | |
| SJ Ventures Private Limited | ₹1.64 Lakh (FY 2022) | •••• | •••• | 95.0% | •••• | Chennai, Tamil Nadu, India |
| Medisch Lifesciences Private Limited | ₹1.63 Lakh (FY 2024) | •••• | •••• | -92.0% | •••• | Delhi, India |
| Tracer Labs Private Limited | ₹1.63 Lakh (FY 2023) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Innovations Unified Technologies Private Limited | ₹1.63 Lakh (FY 2025) | •••• | •••• | -76.0% | •••• | Chittorgarh, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Apithecary Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Apithecary Pharma Private Limited
Apithecary Pharma Private Limited is audited by M.V.NARAYANAREDDY&CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.V.NARAYANAREDDY&CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Apithecary Pharma Private Limited
Apithecary Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munnamgi Radhika Reddy Also directs: Nine Labs Private Limited | Managing Director | 20 Oct 2005 | 20 Years 11 Months | Current |
| Munnamgi Anoushka Reddy Also directs: Nine Labs Private Limited | Director | 15 Mar 2021 | 5 Years 6 Months | Current |
Ownership and Shareholding of Apithecary Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apithecary Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2013 | Andhra Pradesh State Financial Corporation | ₹2.18 Cr | Satisfied |
| 20 Apr 2013 | Andhra Pradesh State Financial Corporation | ₹3 Cr | Satisfied |
| 06 Oct 2009 | Andhra Pradesh State Finacial Corporation | ₹2.16 Cr | Satisfied |
| 30 Jan 2009 | State Bank of India | ₹3.78 Lakh | Satisfied |
| 13 Nov 2008 | State Bank of India | ₹4.5 Cr | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of Apithecary Pharma Private Limited
Apithecary Pharma Private Limited has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sarala Project Works Private Limited |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Feb 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2013 | Funding round | ₹1.1 Cr | Investors: Sarala Project Works Private Limited , an individual |
| Jun 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Apithecary Pharma Private Limited
Apithecary Pharma Private Limited has 13 court cases on record: 9 filed by Apithecary Pharma, 4 filed against it. All cases are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 2 | 0 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against MSN Life Sciences Private Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Vadilal Chemicals Limited | Disposed |
| High Court for State of Telangana | Company petition | Filed against the company by Indkey Infra Projects Private Limited | Disposed |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against Surya Enviro Engineers Company | Disposed |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Apithecary Pharma Private Limited
Employment history and EPFO contributions of people linked to Apithecary Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Apithecary Pharma Private Limited
Apithecary Pharma has one previous CIN (Corporate Identification Number): U24239AP2005PTC047834. The current CIN is U24239TG2005PTC047834, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC047834 | Current |
| U24239AP2005PTC047834 | Previous |
Recent Activity on Apithecary Pharma Private Limited
Apithecary Pharma Private Limited has 10 board changes on record since 2005: 2 appointments and 8 cessations. The latest: Munnamgi Anoushka Reddy ceased to be Additional Director on 30 Sep 2021.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Apithecary Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apithecary Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apithecary Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apithecary Pharma Private Limited
Apithecary Pharma has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apithecary Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apithecary Pharma Private Limited
Apithecary Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2005 (21+ years old) and is registered under CIN U24239TG2005PTC047834.
Apithecary Pharma reported revenue of ₹1.67 Lakh for FY 2025 (up 17% YoY).
Apithecary Pharma has 2 current directors:
- Munnamgi Radhika Reddy - Managing Director
- Munnamgi Anoushka Reddy - Director
Apithecary Pharma reported a net profit of ₹1.06 Lakh (net margin 63.3%) and EBITDA of ₹1.06 Lakh (EBITDA margin 63.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apithecary Pharma is 10% over three years and 3% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
No. Apithecary Pharma has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Apithecary Pharma is U24239TG2005PTC047834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apithecary Pharma has 13 court cases on record: 9 filed by the company and 4 filed against it. Most are in the district courts.
Apithecary Pharma was incorporated on 20 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
Apithecary Pharma has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017.
The peers of Apithecary Pharma by revenue are Naturalle Health Products Pvt Ltd, Biomarq Labs Private Limited, PNJT Realty Private Limited, Ayurvisharada Formulations Private Limited, Vidalife Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).